1. UKPDS Study Group (UKPDS 39). BMJ 1998;317:713 2. AASK Study.JAMA 2002; 288:2421 3. Studio ALLHAT. JAMA 2002; 228:2981-2987 4. JAMA 2003; 288:2421 5. Lancet 2003; 362:1527 6. JNC 7. JAMA 2003; 289:3560 7. Journal of Hypertension 2003; 21:1011 8. British Hypertension Society.BMJ 2004; 328:634 9. Studio CHARM. Lancet 2003; 362:759-781 10.Studio COOPERATE. Lancet 2003; 361:117-24 11.Grossman E et al. Drug Saf 1998; 19:99 12.Grossman E et al. JAMA 1996; 276:1328 13.Campbell NC & Murchie P. BMJ 2004; 329:523 14.Nissen SE et al for the CAMELOT Investigators.JAMA 2004; 292:2217-2225. 15.Pepine CJ. JAMA 2004; 292:2271-2273 16.Carlberg B et al.Lancet 2004; 364: 1684-89 17.Wright JM. CMAJ 2000; 163:188-192 18. Lindholm LH et al. Should Beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005 Oct 29; 366: 1545-1553 19. Casas JP et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes : systematic review and meta-analysis. Lancet 2005 Dec 10; 366: 2026-2033 20. EQM. Battaggia A e Vaona A. Liberare la zia scema dalla soffitta rende inutili le metanalisi? In www.pillole.org/public/aspnuke/downloads.asp?id=141 21. Psaty BM et al.Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277:739 22. Messerli F et al. Are Beta blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998; 279:1903. 23. Kostis JB et al. Chlorthalidone based treatment improves long-term outcomes associated with isolated systolic hypertension, especially among patients with diabetes. Am J Cardiol 2005; 95:29 24. Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic. A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Arch Intern Med. 2005 Apr 25; 165:936-946. 25. Rahman M et al. for the ALLHAT Collaborative Research Study Group. Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate . Ann Intern Med 2006 Feb 7; 144: 172-180 26. Khan N et al. Re-examining the efficacy of ß-blockers for the treatment of hypertension: a meta-analysis. CMAJ 2006 Jun 6; 174: 1737-1742 27. Whelton PK et al. for the ALLHAT Collaborative Research Group. Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) . Arch Intern Med. 2005 Jun 27;165:1401-1409 28. Sarwat I. Chaudhry et al. Systolic Hypertension in Older Persons. JAMA. 2004 Sept 01; 292:1074-1080 29. Rastas S et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc 2006 Jun; 54:912-8. 30. http://www.nice.org.uk/download.aspx?o=CG034fullguideline 31. http://www.pillole.org/public/aspnuke/news.asp?id=2683 32. Wiysonge CS et al. Beta-blockers for hypertension. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD002003. 33. Beckett NS et al. Treatment of Hypertension in Patients 80 Years of Age or Older. N Engl J Med 2008 May 1; 358:1887-1898.
|
|
